Thomson, BJ; Kwong, G; Ratib, S; Sweeting, M; Ryder, SD; de Angelis, D; Grieve, R; Irving, WL; (2008) Response rates to combination therapy for chronic HCV infection in a clinical setting and derivation of probability tables for individual patient management. Journal of viral hepatitis, 15 (4). pp. 271-278. ISSN 1352-0504 DOI: https://doi.org/10.1111/j.1365-2893.2007.00941.x Full text not available from this repository.

van Leeuwen, DJ; Yee, LJ; Langner, RG; (2002) 24 weeks of interferon-ribavirin therapy should not routinely be given to all hepatitis C patients. The American journal of gastroenterology, 97 (2). pp. 497-8. ISSN 0002-9270 DOI: https://doi.org/10.1016/S0002-9270(01)04074-6 Full text not available from this repository.

Yee, LJ; Perez, KA; Tang, J; van Leeuwen, DJ; Kaslow, RA; (2003) Association of CTLA4 polymorphisms with sustained response to interferon and ribavirin therapy for chronic hepatitis C virus infection. The Journal of infectious diseases, 187 (8). pp. 1264-71. ISSN 0022-1899 DOI: https://doi.org/10.1086/374561 Full text not available from this repository.